Immunohistochemical evaluation of MMP-2, MMP-9 and CD31/ microvascular density in squamous cell carcinomas of the floor of the mouth

Brazilian Dental Journal

Volumn 24, Issue 1, 2013, Pages 3-9

  Monteiro Amado, Flávio ^a   Castro Silva, Igor Iuco ^b   Lima, Cristina Jardelino de ^b   Soares, Fernando Augusto ^c   Kowalski, Luiz Paulo ^c   Granjeiro, José Mauro ^b,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

Author keywords

Carcinoma; Lymphatic; Matrix metalloproteinase 2; Matrix metalloproteinase 9; Metastasis; Neovascularization; Pathologic; Squamous cell

Indexed keywords

CD31 ANTIGEN; GELATINASE A; GELATINASE B;

ADULT; AGED; ARTICLE; CANCER STAGING; CHI SQUARE DISTRIBUTION; ENZYME IMMUNOASSAY; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOLOGY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; METABOLISM; MICROVASCULATURE; MIDDLE AGED; MOUTH; MOUTH TUMOR; NEOVASCULARIZATION (PATHOLOGY); NONPARAMETRIC TEST; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR INVASION; VASCULARIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROVESSELS; MIDDLE AGED; MOUTH FLOOR; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84876919804     PISSN: 01036440     EISSN: 18064760     Source Type: Journal    
DOI: 10.1590/0103-6440201301941     Document Type: Article

References (25)

1. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005;5:845-856.
2. Lindenblatt RC, Camisasca DR, Martinez GL, Lourenço SQC, Faria PAS. WHO classification and HRA association with clinicopathological features of oral cancer prognostic factors. Rev Bras Odontol 2009;66:65-70.
3. Görögh T, Beier UH, Bäumken J, Meyer JE, Hoffmann M, Gottschlich S, et al. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas. Head Neck 2006;28:31-39.
4. Tse GM, Chan AW, Yu KH, King AD, Wong KT, Chen GG, et al. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma. Ann Surg Oncol 2007;14:3558-3565.
5. Kurtz KA, Hoffman HT, Zimmerman MB, Robinson RA. Perineural and vascular invasion in oral cavity squamous carcinoma: increased incidence on re-review of slides and by using immunohistochemical enhancement. Arch Pathol Lab Med 2005;129:354-359.
6. Franchi A, Santucci M, Masini E, Sardi I, Paglierani M, Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 2002;95:1902-1910.
7. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-674.
8. Patel BP, Shah PM, Rawal UM, Desai AA, Shah SV, Rawal RM, et al. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 2005;90:81-88.
9. DeClerck YA. Interactions between tumor cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer 2000;36:1258-1268.
10. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-867.
11. Saad S, Gottlieb DJ, Bradstock KF, Overall CM, Bendall LJ. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res 2002;62:283-289.
12. Björklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 2005;1755:37-69.
13. Guttman D, Stern Y, Shpitzer T, Ulanovski D, Druzd T, Feinmesser R. Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue. Oral Oncol 2004;40:798-803.
14. Kim SH, Cho NH, Kim K, Lee JS, Koo BS, Kim JH, et al. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. J Surg Oncol 2006;93:330-337.
15. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
16. Gleich LL, Biddinger PW, Duperier FD, Gluckman JL. Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: a clinical-pathologic correlation. Head Neck 1997;19:276-280.
17. Dantas DDL, Ramos CCF, Costa ALL, Souza LB, Pereira Pinto L. Clinical-pathological parameters in squamous cell carcinoma of the tongue. Braz Dent J 2003;14:22-25.
18. Shang ZJ, Li ZB, Li JR. VEGF is up-regulated by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: in vitro and in vivo studies. Int J Oral Maxillofac Surg 2006;35:533-538.
19. Li C, Shintani S, Terakado N, Klosek SK, Ishikawa T, Nakashiro K, et al. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas. Int J Oral Maxillofac Surg 2005;34:559-565.
20. Warner KA, Miyazawa M, Cordeiro MM, Love WJ, Pinsky MS, Neiva KG, et al. Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling. Neoplasia 2008;10:131-139.
21. Neves AC, Mesquita RA, Novelli MD, Toddai E, Sousa SOM. Comparison between immunohistochemical expression of cyclin D1 and p21 and histological malignancy graduation of oral squamous cell carcinomas. Braz Dent J 2004;15:93-98.
22. Siriwardena BS, Tilakaratne A, Amaratunga EA, Tilakartne WM. Demographic, aetiological and survival differences of oral squamous cell carcinoma in the young and the old in Sri Lanka. Oral Oncol 2006;42:831-836.
23. Selander D, Sjöstrand J. Longitudinal spread of intraneurally injected local anesthetics. An experimental study of the initial neural distribution following intraneural injections. Acta Anaesthesiol Scand 1978;22:622-634.
24. Brown B, Barnes L, Mazariegos J, Taylor F, Johnson J, Wagner RL. Prognostic factors in mobile tongue and floor of mouth carcinoma. Cancer 1989;64:1195-1202.
25. Wang L, Sun M, Jiang Y, Yang L, Lei D, Lu C, et al. Nerve growth factor and tyrosine kinase A in human salivary adenoid cystic carcinoma: expression patterns and effects on in vitro invasive behavior. J Oral Maxillofac Surg 2006;64:636-641.